2seventy bio Inc (NASDAQ: TSVT) is -12.24% lower on its value in year-to-date trading and has touched a low of $2.35 and a high of $6.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TSVT stock was last observed hovering at around $2.74 in the last trading session, with the day’s loss setting it -0.16%.
Currently trading at $2.58, the stock is 1.12% and -14.79% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.81 million and changing -5.84% at the moment leaves the stock -37.14% off its SMA200. TSVT registered -54.34% loss for a year compared to 6-month loss of -35.82%. The firm has a 50-day simple moving average (SMA 50) of $3.0394 and a 200-day simple moving average (SMA200) of $4.1141.
The stock witnessed a -2.27% gain in the last 1 month and extending the period to 3 months gives it a -42.79%, and is -1.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.17% over the week and 7.14% over the month.
2seventy bio Inc (TSVT) has around 274 employees, a market worth around $133.10M and $45.62M in sales. Profit margin for the company is -207.25%. Distance from 52-week low is 10.02% and -59.69% from its 52-week high. The company has generated returns on investments over the last 12 months (-20.57%).
with sales reaching $13.12M over the same period.The EPS is expected to grow by 81.88% this year, but quarterly earnings will post -48.68% year-over-year. Quarterly sales are estimated to grow 22.77% in year-over-year returns.
156.0 institutions hold shares in 2seventy bio Inc (TSVT), with institutional investors hold 94.53% of the company’s shares. The shares outstanding are 51.51M, and float is at 48.39M with Short Float at 10.49%. Institutions hold 90.52% of the Float.
The top institutional shareholder in the company is KYNAM CAPITAL MANAGEMENT, LP with over 5.95 million shares valued at $22.92 million. The investor’s holdings represent 11.4341 of the TSVT Shares outstanding. As of 2024-06-30, the second largest holder is GOLDMAN SACHS GROUP INC with 4.14 million shares valued at $15.93 million to account for 7.9465 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.66 million shares representing 7.0308 and valued at over $14.09 million, while VANGUARD GROUP INC holds 6.9696 of the shares totaling 3.63 million with a market value of $13.97 million.
2seventy bio Inc (TSVT) Insider Activity
The most recent transaction is an insider sale by Snow Jessica,. SEC filings show that Snow Jessica sold 5,114 shares of the company’s common stock on Jan 06 ’25 at a price of $2.79 per share for a total of $14289.0. Following the sale, the insider now owns 0.15 million shares.
2seventy bio Inc disclosed in a document filed with the SEC on Jan 03 ’25 that Snow Jessica sold a total of 1,000 shares of the company’s common stock. The trade occurred on Jan 03 ’25 and was made at $2.94 per share for $2936.0. Following the transaction, the insider now directly holds 0.15 million shares of the TSVT stock.
Still, SEC filings show that on Jan 07 ’25, Snow Jessica disposed off 186 shares at an average price of $2.64 for $491.0. The insider now directly holds 147,179 shares of 2seventy bio Inc (TSVT).
